Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053398 · ClinicalTrials.gov registry record · Early Phase 1
Vasopressor Outcomes in Spine Surgery
A Early Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 101
- Enrollment target
NCT06053398 is a Early Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 101 participants.
The verdict
NCT06053398, a Early Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 101 participants
- Enrollment target
Study Summary
This is a prospective, randomized control trial comparing norepinephrine versus phenylephrine for vasopressor support in patients undergoing elective spinal fusion surgery.
Interventions
- DRUG Norepinephrine
- DRUG Phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2024-12-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053398
The ClinicalTrials.gov registry entry for NCT06053398 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Norepinephrine is the first listed.
NCT06053398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06053398 about?
NCT06053398 is a clinical study titled "Vasopressor Outcomes in Spine Surgery". This is a prospective, randomized control trial comparing norepinephrine versus phenylephrine for vasopressor support in patients undergoing elective spinal fusion surgery.
What is the current status of trial NCT06053398?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 101 participants. The study started on 2023-11-21. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT06053398?
The interventions under investigation include: Norepinephrine (DRUG), Phenylephrine (DRUG).
Who is sponsoring clinical trial NCT06053398?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.